Sex-related differences in the insulin resistance syndrome

被引:11
作者
Corry D.B. [1 ]
机构
[1] Olive View-UCLA Medical Center, Sylmar, CA 91342
关键词
Glucocorticoid Receptor; Arterioscler Thromb Vasc Biol; Visceral Obesity; Insulin Resistance Syndrome; Salt Sensitivity;
D O I
10.1007/s11906-001-0024-8
中图分类号
学科分类号
摘要
In the insulin resistance (IR) syndrome, sex-specific differences have been reported. First, hypertension more often correlates with hyperinsulinemia in women than in men with the IR syndrome. In addition, salt sensitivity of blood pressure appears to be independent of the activity of the renin-angiotensin system in women, whereas in men there is a strong correlation between the two variables. Secondly, the dyslipidemia found in women with the IR syndrome is characterized by less postprandial plasma insulin, triglycerides, and fatty acid response to a standardized meal. However, this sex difference in lipids disappears after correction for visceral fat mass. Fat physiology and biochemistry differ between the two sexes. In women, adipose cells express less glucocorticoid receptors and less 11b-hydroxysteroid dehydrogenase. In women visceral fat accumulation appears to be a constant feature of the IR syndrome but in men the syndrome can be present without central obesity. Lastly, during the reproductive years of women, the IR syndrome, such as in pre-eclampsia, may cause fetal growth retardation that has been proposed together with maternal malnutrition to be at the origin of the increased risk for impaired glucose tolerance, hyperinsulinemia, and hypertension in adult life. This gives yet another dimension to this disease in women since in essence they may ultimately transmit this syndrome to both sexes. Copyright © 2001 by Current Science Inc.
引用
收藏
页码:124 / 128
页数:4
相关论文
共 42 条
  • [1] Reaven G.M., Role of insulin resistance in human disease, Diabetes, 37, pp. 1595-1607, (1988)
  • [2] Defronzo R.A., Ferrannini E., Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease, Diabetes Care, 14, pp. 173-194, (1991)
  • [3] Furman R.H., Are gonadal hormones (estrogens and androgens) of significance in the development of ischemic heart disease?, Ann NY Sci, 149, pp. 822-833, (1968)
  • [4] Trevisan M., Liu J., Bahsas B.F., Menotti M., Syndrome X and mortality: A population-based study, Am J Epidemiol, 148, pp. 958-966, (1998)
  • [5] Donahue R.P., Orchard T.J., Becker D.J., Et al., Sex difference in the coronary heart disease risk profile: A possible role for insulin. The Beaver County Study, Am J Epidemiol, 125, pp. 650-657, (1987)
  • [6] Ferrannini E., Buzzigoli G., Bonnadonna R., Et al., Insulin resistance in essential hypertension, N Engl J Med, 17, pp. 350-357, (1987)
  • [7] Gm R., Hoffman B.B., A role for insulin in the aetiology and course of hypertension, Lancet, 2, pp. 435-436, (1987)
  • [8] Haffner S.M., Ferrannini E., Hazuda H.P., Stern M.P., Clustering of cardiovascular risks factors in confirmed prehypertensive individuals, Hypertension, 20, pp. 38-45, (1992)
  • [9] Falkner B., Hulman S., Kushner H., Insulin-stimulated glucose utilization and borderline hypertension in young adult blacks, Hypertension, 22, pp. 18-25, (1993)
  • [10] Haffner S.M., Valdez R., Morales P.A., Et al., Greater effect of glycemia on incidence of hypertension in women than in men, Diabetes Care, 15, pp. 1277-1284, (1992)